Researchers Researchers - Laboratory Directors Cara Tannenbaum
| Cara Tannenbaum |
|
Biography With over 10 years of consecutive funding from the Canadian Institutes of Health Research as well as an FRS-Q chercheur-boursier senior award, Dr. Tannenbaum is a leader in cutting-edge geriatric research both nationally and internationally. She is the recipient of a 2004 New Investigator Award from the American Geriatrics Society and the 2008 May-Cohen Gender Equity Award from the Association of Faculties of Medicine of Canada. In 2008, Dr. Tannenbaum became the inaugural Chair of the Michel Saucier Endowed Fund in Geriatric Pharmacology, Health and Aging of the Faculty of Pharmacy at the Université de Montréal. In 2013, the Institute of Aging of the Canadian Institutes Health Research presented her with the Betty-Havens Knowledge Transfer Award. She holds an appointment as Full Professor in the Faculties of Medicine and Pharmacy at the Université de Montréal. As Director of the Geriatric Incontinence Clinic at the Institut universitaire de gériatrie de Montréal, her clinical practice fuels her vision for her patient-oriented research program. Dr. Tannenbaum obtained her medical degree at McGill University in 1994 and subsequently obtained specialty training in geriatric medicine and older women`s health. She pursued a Master’s Degree in Epidemiology and Biostatistics in 2002 at McGill University. Dr. Tannenbaum was appointed Scientific Director of the CIHR Institute of Gender and Health commencing January 2015. In this role she works with the Canadian gender, sex and health research community and stakeholders to identify research priorities, develop research-funding opportunities, strengthen research capacity, build partnerships and translate research evidence to improve the health of Canadians. Research Program Dr. Cara Tannenbaum’s research focuses on best practices in pharmaceutical care for the elderly, better understanding the drug-brain-bladder connection in women and men, self-management, mental health indicators and outcomes, and gender-based analysis. Through her work, she aims to deconstruct ageism for issues related to incontinence, cognitive impairment, mental health and inappropriate prescribing. She is currently leading an international clinical trial funded by the European Research Area on Aging to increase healthy active life expectancy for women across France, the UK and Canada. She holds partnerships with the Public Health Agency of Canada, Public Health England and Santé publique de la France. Dr. Tannenbaum is an active member of the Polypharmacy Committee for the Institut national de santé publique du Québec, and a strong advocate for interprofessional collaboration to optimize healthy aging across the lifespan. Links Proton Pump Inhibitors De-prescribing Brochure Sulfonylurea Diabetes Medication De-Prescribing Brochure Antipsychotic Medication De-Prescribing Brochure Antihistamine De-Prescribing Brochure Sedative-Hypnotic Medication De-Prescribing Brochure Older Women and Men's Health Priorities in Canada 
|
